医学
内科学
系统性红斑狼疮
狼疮性肾炎
免疫学
红斑狼疮
抗体
疾病
作者
David Jayne,Brad H. Rovin,Eduardo Mysler,Richard Furie,Frédéric Houssiau,Teodora Trasieva,J. Knagenhjelm,Erik Schwetje,Yen Lin Chia,Raj Tummala,Catharina Lindholm
标识
DOI:10.1136/annrheumdis-2021-221478
摘要
To assess the efficacy and safety of the type I interferon receptor antibody, anifrolumab, in patients with active, biopsy-proven, Class III/IV lupus nephritis.
科研通智能强力驱动
Strongly Powered by AbleSci AI